BBS Pharmaceuticals

BBS Pharmaceuticals was an Australian private medicinal cannabis company focused on cultivating, producing, and manufacturing cannabis-based pharmaceutical and wellness products for regulated domestic and international markets. The company was founded in 2017 in South Australia and positioned itself as a licensed operator serving prescription-only medicinal cannabis markets. Public descriptions emphasize cannabis cultivation, manufacturing, and supply rather than a conventional clinical-stage therapeutic pipeline. Reports in February 2023 indicated the business had entered administration, and multiple business data sources now classify it as closed or permanently closed. Available public information does not indicate a broad proprietary drug-development pipeline with named clinical assets.